APO Research
Talk to an analyst

APO RESEARCH · REPORT

Direct Acting Antivirals

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Direct Acting Antivirals Industry Growth and Trends Forecast to 2032

27 December 2025103 pages

Choose your research edition.

Industry ResearchDirect Acting Antivirals Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Direct Acting Antivirals Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Direct Acting Antivirals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Direct Acting Antivirals Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Direct Acting Antivirals Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Direct Acting Antivirals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Direct Acting Antivirals is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Direct Acting Antivirals is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Direct Acting Antivirals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Direct Acting Antivirals include AbbVie, Asegua Therapeutics, Bristol Myers Squibb, Gilead Sciences, Merck, Ascletis Pharma, Cosunter pharmaceutical, Kawin Technology and Sanhome Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Direct Acting Antivirals market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Direct Acting Antivirals market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Direct Acting Antivirals market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Direct Acting Antivirals.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Direct Acting Antivirals market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Direct Acting Antivirals Market by Company

AbbVie

Asegua Therapeutics

Bristol Myers Squibb

Gilead Sciences

Merck

Ascletis Pharma

Cosunter pharmaceutical

Kawin Technology

Sanhome Pharmaceutical

Beijing Sihuan Pharmaceutical

YiChang HEC ChangJiang Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Direct Acting Antivirals Segment by Type

Pangenotypic

Genotype-Specific

Direct Acting Antivirals Segment by Application

Hospital and Clinic

Pharmacy

Other

Direct Acting Antivirals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Direct Acting Antivirals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Direct Acting Antivirals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Direct Acting Antivirals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Direct Acting Antivirals manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Direct Acting Antivirals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pangenotypic Table 2. Major Company of Genotype-Specific Table 3. Global Direct Acting Antivirals Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Direct Acting Antivirals Sales by Type (2021-2026) & (K Units) Table 5. Global Direct Acting Antivirals Sales Market Share in Volume by Type (2021-2026) Table 6. Global Direct Acting Antivirals Sales by Type (2021-2026) & (US$ Million) Table 7. Global Direct Acting Antivirals Sales Market Share in Value by Type (2021-2026) Table 8. Global Direct Acting Antivirals Price by Type (2021-2026) & (US$/Unit) Table 9. Global Direct Acting Antivirals Sales by Type (2027-2032) & (K Units) Table 10. Global Direct Acting Antivirals Sales Market Share in Volume by Type (2027-2032) Table 11. Global Direct Acting Antivirals Sales by Type (2027-2032) & (US$ Million) Table 12. Global Direct Acting Antivirals Sales Market Share in Value by Type (2027-2032) Table 13. Global Direct Acting Antivirals Price by Type (2027-2032) & (US$/Unit) Table 14. North America Direct Acting Antivirals Sales by Type (2021-2026) & (K Units) Table 15. North America Direct Acting Antivirals Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Direct Acting Antivirals Sales by Type (2021-2026) & (K Units) Table 17. Europe Direct Acting Antivirals Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Direct Acting Antivirals Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Direct Acting Antivirals Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Direct Acting Antivirals Sales by Type (2021-2026) & (K Units) Table 21. Latin America Direct Acting Antivirals Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Direct Acting Antivirals Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Direct Acting Antivirals Sales by Type (2021-2026) & (US$ Million) Table 24. Direct Acting Antivirals Industry Trends Table 25. Direct Acting Antivirals Industry Drivers Table 26. Direct Acting Antivirals Industry Opportunities and Challenges Table 27. Direct Acting Antivirals Industry Restraints Table 28. Global Direct Acting Antivirals Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Direct Acting Antivirals Revenue Market Share by Company (2021-2026) Table 30. Global Direct Acting Antivirals Sales by Company (2021-2026) & (K Units) Table 31. Global Direct Acting Antivirals Sales Share by Company (2021-2026) Table 32. Global Direct Acting Antivirals Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Direct Acting Antivirals Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Direct Acting Antivirals Major Company Production Sites and Headquarters Table 35. Global Direct Acting Antivirals Company, Product Type & Application Table 36. Global Direct Acting Antivirals Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Direct Acting Antivirals by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Direct Acting Antivirals Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Direct Acting Antivirals Sales by Region (2021-2026) & (K Units) Table 41. Global Direct Acting Antivirals Sales Market Share in Volume by Region (2021-2026) Table 42. Global Direct Acting Antivirals Sales by Region (2021-2026) & (US$ Million) Table 43. Global Direct Acting Antivirals Sales Market Share in Value by Region (2021-2026) Table 44. Global Direct Acting Antivirals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Direct Acting Antivirals Sales by Region (2027-2032) & (K Units) Table 46. Global Direct Acting Antivirals Sales Market Share in Volume by Region (2027-2032) Table 47. Global Direct Acting Antivirals Sales by Region (2027-2032) & (US$ Million) Table 48. Global Direct Acting Antivirals Sales Market Share in Value by Region (2027-2032) Table 49. Global Direct Acting Antivirals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Direct Acting Antivirals Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Direct Acting Antivirals Sales by Application (2021-2026) & (K Units) Table 52. Global Direct Acting Antivirals Sales Market Share in Volume by Application (2021-2026) Table 53. Global Direct Acting Antivirals Sales by Application (2021-2026) & (US$ Million) Table 54. Global Direct Acting Antivirals Sales Market Share in Value by Application (2021-2026) Table 55. Global Direct Acting Antivirals Price by Application (2021-2026) & (US$/Unit) Table 56. Global Direct Acting Antivirals Sales by Application (2027-2032) & (K Units) Table 57. Global Direct Acting Antivirals Sales Market Share in Volume by Application (2027-2032) Table 58. Global Direct Acting Antivirals Sales by Application (2027-2032) & (US$ Million) Table 59. Global Direct Acting Antivirals Sales Market Share in Value by Application (2027-2032) Table 60. Global Direct Acting Antivirals Price by Application (2027-2032) & (US$/Unit) Table 61. North America Direct Acting Antivirals Sales by Application (2021-2026) & (K Units) Table 62. North America Direct Acting Antivirals Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Direct Acting Antivirals Sales by Application (2021-2026) & (K Units) Table 64. Europe Direct Acting Antivirals Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Direct Acting Antivirals Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Direct Acting Antivirals Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Direct Acting Antivirals Sales by Application (2021-2026) & (K Units) Table 68. Latin America Direct Acting Antivirals Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Direct Acting Antivirals Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Direct Acting Antivirals Sales by Application (2021-2026) & (US$ Million) Table 71. AbbVie Company Information Table 72. AbbVie Business Overview Table 73. AbbVie Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AbbVie Direct Acting Antivirals Product Portfolio Table 75. AbbVie Recent Development Table 76. Asegua Therapeutics Company Information Table 77. Asegua Therapeutics Business Overview Table 78. Asegua Therapeutics Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Asegua Therapeutics Direct Acting Antivirals Product Portfolio Table 80. Asegua Therapeutics Recent Development Table 81. Bristol Myers Squibb Company Information Table 82. Bristol Myers Squibb Business Overview Table 83. Bristol Myers Squibb Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Bristol Myers Squibb Direct Acting Antivirals Product Portfolio Table 85. Bristol Myers Squibb Recent Development Table 86. Gilead Sciences Company Information Table 87. Gilead Sciences Business Overview Table 88. Gilead Sciences Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Gilead Sciences Direct Acting Antivirals Product Portfolio Table 90. Gilead Sciences Recent Development Table 91. Merck Company Information Table 92. Merck Business Overview Table 93. Merck Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Merck Direct Acting Antivirals Product Portfolio Table 95. Merck Recent Development Table 96. Ascletis Pharma Company Information Table 97. Ascletis Pharma Business Overview Table 98. Ascletis Pharma Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Ascletis Pharma Direct Acting Antivirals Product Portfolio Table 100. Ascletis Pharma Recent Development Table 101. Cosunter pharmaceutical Company Information Table 102. Cosunter pharmaceutical Business Overview Table 103. Cosunter pharmaceutical Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Cosunter pharmaceutical Direct Acting Antivirals Product Portfolio Table 105. Cosunter pharmaceutical Recent Development Table 106. Kawin Technology Company Information Table 107. Kawin Technology Business Overview Table 108. Kawin Technology Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Kawin Technology Direct Acting Antivirals Product Portfolio Table 110. Kawin Technology Recent Development Table 111. Sanhome Pharmaceutical Company Information Table 112. Sanhome Pharmaceutical Business Overview Table 113. Sanhome Pharmaceutical Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Sanhome Pharmaceutical Direct Acting Antivirals Product Portfolio Table 115. Sanhome Pharmaceutical Recent Development Table 116. Beijing Sihuan Pharmaceutical Company Information Table 117. Beijing Sihuan Pharmaceutical Business Overview Table 118. Beijing Sihuan Pharmaceutical Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Beijing Sihuan Pharmaceutical Direct Acting Antivirals Product Portfolio Table 120. Beijing Sihuan Pharmaceutical Recent Development Table 121. YiChang HEC ChangJiang Pharmaceutical Company Information Table 122. YiChang HEC ChangJiang Pharmaceutical Business Overview Table 123. YiChang HEC ChangJiang Pharmaceutical Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. YiChang HEC ChangJiang Pharmaceutical Direct Acting Antivirals Product Portfolio Table 125. YiChang HEC ChangJiang Pharmaceutical Recent Development Table 126. Chia Tai Tianqing Pharmaceutical Company Information Table 127. Chia Tai Tianqing Pharmaceutical Business Overview Table 128. Chia Tai Tianqing Pharmaceutical Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Chia Tai Tianqing Pharmaceutical Direct Acting Antivirals Product Portfolio Table 130. Chia Tai Tianqing Pharmaceutical Recent Development Table 131. North America Direct Acting Antivirals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. North America Direct Acting Antivirals Sales by Country (2021-2026) & (K Units) Table 133. North America Direct Acting Antivirals Sales Market Share by Country (2021-2026) Table 134. North America Direct Acting Antivirals Sales Forecast by Country (2027-2032) & (K Units) Table 135. North America Direct Acting Antivirals Sales Market Share Forecast by Country (2027-2032) Table 136. North America Direct Acting Antivirals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Direct Acting Antivirals Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Direct Acting Antivirals Market Share by Country (2021-2026) Table 139. North America Direct Acting Antivirals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Direct Acting Antivirals Market Share Forecast by Country (2027-2032) Table 141. Europe Direct Acting Antivirals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Europe Direct Acting Antivirals Sales by Country (2021-2026) & (K Units) Table 143. Europe Direct Acting Antivirals Sales Market Share by Country (2021-2026) Table 144. Europe Direct Acting Antivirals Sales Forecast by Country (2027-2032) & (K Units) Table 145. Europe Direct Acting Antivirals Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Direct Acting Antivirals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Direct Acting Antivirals Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Direct Acting Antivirals Market Share by Country (2021-2026) Table 149. Europe Direct Acting Antivirals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Direct Acting Antivirals Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Direct Acting Antivirals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Direct Acting Antivirals Sales by Country (2021-2026) & (K Units) Table 153. Asia-Pacific Direct Acting Antivirals Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Direct Acting Antivirals Sales Forecast by Country (2027-2032) & (K Units) Table 155. Asia-Pacific Direct Acting Antivirals Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Direct Acting Antivirals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Direct Acting Antivirals Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Direct Acting Antivirals Market Share by Country (2021-2026) Table 159. Asia-Pacific Direct Acting Antivirals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Direct Acting Antivirals Market Share Forecast by Country (2027-2032) Table 161. Latin America Direct Acting Antivirals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Latin America Direct Acting Antivirals Sales by Country (2021-2026) & (K Units) Table 163. Latin America Direct Acting Antivirals Sales Market Share by Country (2021-2026) Table 164. Latin America Direct Acting Antivirals Sales Forecast by Country (2027-2032) & (K Units) Table 165. Latin America Direct Acting Antivirals Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Direct Acting Antivirals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Direct Acting Antivirals Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Direct Acting Antivirals Market Share by Country (2021-2026) Table 169. Latin America Direct Acting Antivirals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Direct Acting Antivirals Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Direct Acting Antivirals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Direct Acting Antivirals Sales by Country (2021-2026) & (K Units) Table 173. Middle East and Africa Direct Acting Antivirals Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Direct Acting Antivirals Sales Forecast by Country (2027-2032) & (K Units) Table 175. Middle East and Africa Direct Acting Antivirals Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Direct Acting Antivirals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Direct Acting Antivirals Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Direct Acting Antivirals Market Share by Country (2021-2026) Table 179. Middle East and Africa Direct Acting Antivirals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Direct Acting Antivirals Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Direct Acting Antivirals Distributors List Table 184. Direct Acting Antivirals Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Direct Acting Antivirals Image Figure 2. Global Direct Acting Antivirals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Direct Acting Antivirals Market Size (2021-2032) & (US$ Million) Figure 4. Global Direct Acting Antivirals Sales (2021-2032) & (K Units) Figure 5. Pangenotypic Image Figure 6. Global Pangenotypic Sales YoY Growth (2021-2032) & (K Units) Figure 7. Genotype-Specific Image Figure 8. Global Genotype-Specific Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Direct Acting Antivirals Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Direct Acting Antivirals Market Share by Type 2025 VS 2032 Figure 11. North America Direct Acting Antivirals Sales Market Share in Volume by Type in 2025 Figure 12. North America Direct Acting Antivirals Sales Market Share in Value by Type in 2025 Figure 13. Europe Direct Acting Antivirals Sales Market Share in Volume by Type in 2025 Figure 14. Europe Direct Acting Antivirals Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Direct Acting Antivirals Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Direct Acting Antivirals Sales Market Share in Value by Type in 2025 Figure 17. Latin America Direct Acting Antivirals Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Direct Acting Antivirals Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Direct Acting Antivirals Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Direct Acting Antivirals Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Direct Acting Antivirals Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Direct Acting Antivirals Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Direct Acting Antivirals Market Share by Application 2025 VS 2032 Figure 31. North America Direct Acting Antivirals Sales Market Share in Volume by Application in 2025 Figure 32. North America Direct Acting Antivirals Sales Market Share in Value by Application in 2025 Figure 33. Europe Direct Acting Antivirals Sales Market Share in Volume by Application in 2025 Figure 34. Europe Direct Acting Antivirals Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Direct Acting Antivirals Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Direct Acting Antivirals Sales Market Share in Value by Application in 2025 Figure 37. Latin America Direct Acting Antivirals Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Direct Acting Antivirals Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Direct Acting Antivirals Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Direct Acting Antivirals Sales Market Share in Value by Application in 2025 Figure 41. North America Direct Acting Antivirals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Direct Acting Antivirals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Direct Acting Antivirals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Direct Acting Antivirals Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Direct Acting Antivirals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Direct Acting Antivirals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Direct Acting Antivirals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Direct Acting Antivirals Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Direct Acting Antivirals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Direct Acting Antivirals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Direct Acting Antivirals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Direct Acting Antivirals Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Direct Acting Antivirals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Direct Acting Antivirals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Direct Acting Antivirals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Direct Acting Antivirals Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Direct Acting Antivirals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Direct Acting Antivirals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Direct Acting Antivirals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Direct Acting Antivirals Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Direct Acting Antivirals Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Direct Acting Antivirals Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Pangenotypic
  • Genotype-Specific
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • AbbVie
  • Asegua Therapeutics
  • Bristol Myers Squibb
  • Gilead Sciences
  • Merck
  • Ascletis Pharma
  • Cosunter pharmaceutical
  • Kawin Technology
  • Sanhome Pharmaceutical
  • Beijing Sihuan Pharmaceutical
  • YiChang HEC ChangJiang Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Direct Acting Antivirals Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Direct Acting Antivirals Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Direct Acting Antivirals Market by Type
  6. 1.3.1 Pangenotypic
  7. 1.3.2 Genotype-Specific
  8. 1.4 Global Direct Acting Antivirals Market Size by Type
  9. 1.4.1 Global Direct Acting Antivirals Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Direct Acting Antivirals Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Direct Acting Antivirals Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Direct Acting Antivirals Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Direct Acting Antivirals Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Direct Acting Antivirals Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Direct Acting Antivirals Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Direct Acting Antivirals Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Direct Acting Antivirals Industry Trends
  2. 2.2 Direct Acting Antivirals Industry Drivers
  3. 2.3 Direct Acting Antivirals Industry Opportunities and Challenges
  4. 2.4 Direct Acting Antivirals Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Direct Acting Antivirals Revenue (2021-2026)
  2. 3.2 Global Top Players by Direct Acting Antivirals Sales (2021-2026)
  3. 3.3 Global Top Players by Direct Acting Antivirals Price (2021-2026)
  4. 3.4 Global Direct Acting Antivirals Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Direct Acting Antivirals Major Company Production Sites & Headquarters
  6. 3.6 Global Direct Acting Antivirals Company, Product Type & Application
  7. 3.7 Global Direct Acting Antivirals Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Direct Acting Antivirals Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Direct Acting Antivirals Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Direct Acting Antivirals Tier 1, Tier 2, and Tier 3
4 Direct Acting Antivirals Regional Status and Outlook
  1. 4.1 Global Direct Acting Antivirals Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Direct Acting Antivirals Historic Market Size by Region
  3. 4.2.1 Global Direct Acting Antivirals Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Direct Acting Antivirals Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Direct Acting Antivirals Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Direct Acting Antivirals Forecasted Market Size by Region
  7. 4.3.1 Global Direct Acting Antivirals Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Direct Acting Antivirals Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Direct Acting Antivirals Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Direct Acting Antivirals by Application
  1. 5.1 Direct Acting Antivirals Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Direct Acting Antivirals Market Size by Application
  6. 5.2.1 Global Direct Acting Antivirals Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Direct Acting Antivirals Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Direct Acting Antivirals Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Direct Acting Antivirals Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Direct Acting Antivirals Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Direct Acting Antivirals Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Direct Acting Antivirals Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Direct Acting Antivirals Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AbbVie
  2. 6.1.1 AbbVie Company Information
  3. 6.1.2 AbbVie Business Overview
  4. 6.1.3 AbbVie Direct Acting Antivirals Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AbbVie Direct Acting Antivirals Product Portfolio
  6. 6.1.5 AbbVie Recent Developments
  7. 6.2 Asegua Therapeutics
  8. 6.2.1 Asegua Therapeutics Company Information
  9. 6.2.2 Asegua Therapeutics Business Overview
  10. 6.2.3 Asegua Therapeutics Direct Acting Antivirals Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Asegua Therapeutics Direct Acting Antivirals Product Portfolio
  12. 6.2.5 Asegua Therapeutics Recent Developments
  13. 6.3 Bristol Myers Squibb
  14. 6.3.1 Bristol Myers Squibb Company Information
  15. 6.3.2 Bristol Myers Squibb Business Overview
  16. 6.3.3 Bristol Myers Squibb Direct Acting Antivirals Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bristol Myers Squibb Direct Acting Antivirals Product Portfolio
  18. 6.3.5 Bristol Myers Squibb Recent Developments
  19. 6.4 Gilead Sciences
  20. 6.4.1 Gilead Sciences Company Information
  21. 6.4.2 Gilead Sciences Business Overview
  22. 6.4.3 Gilead Sciences Direct Acting Antivirals Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Gilead Sciences Direct Acting Antivirals Product Portfolio
  24. 6.4.5 Gilead Sciences Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Direct Acting Antivirals Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck Direct Acting Antivirals Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Ascletis Pharma
  32. 6.6.1 Ascletis Pharma Company Information
  33. 6.6.2 Ascletis Pharma Business Overview
  34. 6.6.3 Ascletis Pharma Direct Acting Antivirals Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ascletis Pharma Direct Acting Antivirals Product Portfolio
  36. 6.6.5 Ascletis Pharma Recent Developments
  37. 6.7 Cosunter pharmaceutical
  38. 6.7.1 Cosunter pharmaceutical Company Information
  39. 6.7.2 Cosunter pharmaceutical Business Overview
  40. 6.7.3 Cosunter pharmaceutical Direct Acting Antivirals Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Cosunter pharmaceutical Direct Acting Antivirals Product Portfolio
  42. 6.7.5 Cosunter pharmaceutical Recent Developments
  43. 6.8 Kawin Technology
  44. 6.8.1 Kawin Technology Company Information
  45. 6.8.2 Kawin Technology Business Overview
  46. 6.8.3 Kawin Technology Direct Acting Antivirals Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Kawin Technology Direct Acting Antivirals Product Portfolio
  48. 6.8.5 Kawin Technology Recent Developments
  49. 6.9 Sanhome Pharmaceutical
  50. 6.9.1 Sanhome Pharmaceutical Company Information
  51. 6.9.2 Sanhome Pharmaceutical Business Overview
  52. 6.9.3 Sanhome Pharmaceutical Direct Acting Antivirals Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sanhome Pharmaceutical Direct Acting Antivirals Product Portfolio
  54. 6.9.5 Sanhome Pharmaceutical Recent Developments
  55. 6.10 Beijing Sihuan Pharmaceutical
  56. 6.10.1 Beijing Sihuan Pharmaceutical Company Information
  57. 6.10.2 Beijing Sihuan Pharmaceutical Business Overview
  58. 6.10.3 Beijing Sihuan Pharmaceutical Direct Acting Antivirals Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Beijing Sihuan Pharmaceutical Direct Acting Antivirals Product Portfolio
  60. 6.10.5 Beijing Sihuan Pharmaceutical Recent Developments
  61. 6.11 YiChang HEC ChangJiang Pharmaceutical
  62. 6.11.1 YiChang HEC ChangJiang Pharmaceutical Company Information
  63. 6.11.2 YiChang HEC ChangJiang Pharmaceutical Business Overview
  64. 6.11.3 YiChang HEC ChangJiang Pharmaceutical Direct Acting Antivirals Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 YiChang HEC ChangJiang Pharmaceutical Direct Acting Antivirals Product Portfolio
  66. 6.11.5 YiChang HEC ChangJiang Pharmaceutical Recent Developments
  67. 6.12 Chia Tai Tianqing Pharmaceutical
  68. 6.12.1 Chia Tai Tianqing Pharmaceutical Company Information
  69. 6.12.2 Chia Tai Tianqing Pharmaceutical Business Overview
  70. 6.12.3 Chia Tai Tianqing Pharmaceutical Direct Acting Antivirals Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Chia Tai Tianqing Pharmaceutical Direct Acting Antivirals Product Portfolio
  72. 6.12.5 Chia Tai Tianqing Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Direct Acting Antivirals Sales by Country
  2. 7.1.1 North America Direct Acting Antivirals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Direct Acting Antivirals Sales by Country (2021-2026)
  4. 7.1.3 North America Direct Acting Antivirals Sales Forecast by Country (2027-2032)
  5. 7.2 North America Direct Acting Antivirals Market Size by Country
  6. 7.2.1 North America Direct Acting Antivirals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Direct Acting Antivirals Market Size by Country (2021-2026)
  8. 7.2.3 North America Direct Acting Antivirals Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Direct Acting Antivirals Sales by Country
  2. 8.1.1 Europe Direct Acting Antivirals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Direct Acting Antivirals Sales by Country (2021-2026)
  4. 8.1.3 Europe Direct Acting Antivirals Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Direct Acting Antivirals Market Size by Country
  6. 8.2.1 Europe Direct Acting Antivirals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Direct Acting Antivirals Market Size by Country (2021-2026)
  8. 8.2.3 Europe Direct Acting Antivirals Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Direct Acting Antivirals Sales by Country
  2. 9.1.1 Asia-Pacific Direct Acting Antivirals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Direct Acting Antivirals Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Direct Acting Antivirals Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Direct Acting Antivirals Market Size by Country
  6. 9.2.1 Asia-Pacific Direct Acting Antivirals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Direct Acting Antivirals Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Direct Acting Antivirals Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Direct Acting Antivirals Sales by Country
  2. 10.1.1 South America Direct Acting Antivirals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Direct Acting Antivirals Sales by Country (2021-2026)
  4. 10.1.3 South America Direct Acting Antivirals Sales Forecast by Country (2027-2032)
  5. 10.2 South America Direct Acting Antivirals Market Size by Country
  6. 10.2.1 South America Direct Acting Antivirals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Direct Acting Antivirals Market Size by Country (2021-2026)
  8. 10.2.3 South America Direct Acting Antivirals Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Direct Acting Antivirals Sales by Country
  2. 11.1.1 Middle East and Africa Direct Acting Antivirals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Direct Acting Antivirals Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Direct Acting Antivirals Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Direct Acting Antivirals Market Size by Country
  6. 11.2.1 Middle East and Africa Direct Acting Antivirals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Direct Acting Antivirals Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Direct Acting Antivirals Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Direct Acting Antivirals Value Chain Analysis
  2. 12.1.1 Direct Acting Antivirals Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Direct Acting Antivirals Production Mode & Process
  7. 12.2 Direct Acting Antivirals Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Direct Acting Antivirals Distributors
  10. 12.2.3 Direct Acting Antivirals Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst